How it started
History
Caliper Life Sciences was founded in 1995 by Larry Bock and Drs. Michael Knapp, Michael Ramsey and Andreas Manz. as Caliper Technologies, with a focus on microfluidics technology. In 2003, the firm acquired Zymark, a company with a focus in laboratory automation and robotics, and was renamed Caliper Life Sciences.
In October 2005, it acquired NovaScreen Biosciences Corporation a privately held CRO offering pre-clinical drug discovery and development services. In August 2006, it acquired Xenogen Corporation, a developer of in vivo optical imaging systems (IVIS systems) and its division, Xenogen Biosciences, a CRO offering in vivo transgenic animal production, phenotyping, gene targeting and in vivo optical imaging services, which was subsequently acquired by Taconic.
At the end of October 2008, SOTAX, a tester and software developer of medical devices, acquired Caliper's Pharmaceutical Development & Quality Analysis (PDQ) Division for $15.8 Million. On November 10, 2008, Caliper's Auto Trace(r) line of product was acquired by Dionex. In December 2009, Taconic Biosciences acquired XenoGen Biosciences' in vivo pre-clinical CRO, a subsidiary of Caliper Life Sciences. A year later, in December 2010, Caliper purchased Cambridge Research & Instrumentation Inc. for ~$20 million in a cash and stock deal.
In September 2011, PerkinElmer agreed to buy Caliper Life Sciences for $600 million. On November 7, 2011, PerkinElmer completed the acquisition of Caliper Life Sciences for a total net purchase price of approximately $600 million in cash.
From Wikipedia’s article on Caliper Life Sciences, shared under CC BY-SA 4.0.2